Nike Forecast, price target & analysts
Nike Target price 2025 - Analyst rating & recommendation
Nike Classifications & Recommendation:
Nike Price Target
| Target Price | $80.76 |
| Price | $66.54 |
| Potential | 21.37% |
| Number of Estimates | 34 |
| 34 Analysts have issued a price target Nike 2026 . The average Nike target price is $80.76. This is 21.37% higher than the current stock price. The highest price target is $120.00 80.34% , the lowest is $40.00 39.89% . | |
| A rating was issued by 43 analysts: 24 Analysts recommend Nike to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Nike stock has an average upside potential 2026 of 21.37% . Most analysts recommend the Nike stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
33 Analysts have issued a sales forecast Nike 2025 . The average Nike sales estimate is $45.9b . This is 4.16% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $46.3b 3.30% , the lowest is $45.0b 6.02% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $51.4b | 0.38% |
|---|---|---|
| 2025 | $45.9b | 10.70% |
| 2026 | $45.6b | 0.58% |
| 2027 | $48.3b | 5.77% |
| 2028 | $53.3b | 10.40% |
| 2029 | $54.9b | 3.09% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
14 Analysts have issued a Nike forecast for earnings per share. The average Nike EPS is $2.13 . This is 29.24% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.24 25.58% , the lowest is $2.04 32.23% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $3.73 | 15.48% |
|---|---|---|
| 2025 | $2.13 | 42.90% |
| 2026 | $2.08 | 2.35% |
| 2027 | $2.66 | 27.88% |
| 2028 | $3.31 | 24.44% |
| 2029 | $4.18 | 26.28% |
P/E ratio
| Current | 22.14 | 19.75% |
|---|---|---|
| 2025 | 31.27 | 41.24% |
| 2026 | 32.00 | 2.33% |
| 2027 | 25.03 | 21.78% |
| 2028 | 20.10 | 19.70% |
| 2029 | 15.92 | 20.80% |
Based on analysts' sales estimates for 2025, the Nike stock is valued at an EV/Sales of 2.18 and an P/S ratio of 2.14 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 2.09 | 25.09% |
|---|---|---|
| 2025 | 2.18 | 4.21% |
| 2026 | 2.19 | 0.58% |
| 2027 | 2.07 | 5.45% |
| 2028 | 1.88 | 9.42% |
| 2029 | 1.82 | 3.00% |
P/S ratio
| Current | 2.06 | 25.46% |
|---|---|---|
| 2025 | 2.14 | 4.34% |
| 2026 | 2.16 | 0.58% |
| 2027 | 2.04 | 5.46% |
| 2028 | 1.85 | 9.42% |
| 2029 | 1.79 | 3.00% |
Current Nike Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Buy
➜
Buy
|
Unchanged | Mar 21 2025 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Mar 21 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Mar 21 2025 |
| Telsey Advisory Group |
Market Perform
➜
Market Perform
|
Unchanged | Mar 21 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 21 2025 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Mar 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Needham:
Buy
➜
Buy
|
Mar 21 2025 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Mar 21 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Mar 21 2025 |
|
Unchanged
Telsey Advisory Group:
Market Perform
➜
Market Perform
|
Mar 21 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Mar 21 2025 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Mar 21 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Mar 21 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
